biotech / news / / The Manila Times
The Novo Nordisk study POSEIDON - including 18,904 patients across 18 countries - showed that cardiovascular (CV) inflammation remains highly prevalent among people with cardiovascular disease.
The POSEIDON study found 42% of ASCVD patients with CKD or heart failure have CV inflammation.
KEY POINTS
- CV inflammation, measured by hsCRP ≥2 mg/L, persists despite standard cholesterol, blood pressure, and sugar treatments.
- POSEIDON enrolled 18,904 patients across 18 countries from 2023 to 2025, making it one of the largest studies of its kind.
- Recent global guidelines now recommend using elevated hsCRP to guide intensive cardiovascular preventive strategies.
COMPANIES
Summarized by Newsio from The Manila Times. How we summarize →